Eurofins
Last update: November 25, 2020
Biotechnology
France
Its 130 main executivesIts 18 subsidiaries
Create an alert
to follow the executive moves at Eurofins.
Eurofins is one of the...
Most searched biographies at Eurofins
- Gilles Martin, Chairman of the Board and Chief Executive Officer
- Fereshteh Pouchantchi, Independent Non-Executive Director
- Valerie Hanote, Non-Executive Director
Click on an executive to view his biography >
Latest M&A news in Biotechnology.
Integra Lifesciences has acquired ACell (posted on Jan 21, 2021).
Kymab and Sanofi have announced they will merge (posted on Jan 11, 2021).
PerkinElmer has announced the acquisition of Oxford Immunotec (posted on Jan 8, 2021).
Other contacts in the Biotechnology industry
Latest news about Eurofins
Eurofins SAFE HARBOR STATEMENT
- Eurofins Scientific
Eurofins raises EUR 535m following a successful equity issuance
- Eurofins Scientific
Eurofins announces the issuance of c. 900,000 new shares via an accelerated book building offering to institutional investors in order to support its rapid build-up of COVID-19 testing capacities
- Eurofins Scientific
Eurofins announces the success of its Tender Offers on its outstanding 2022 bonds and 2023 bonds
- Eurofins Scientific
Eurofins Technologies launches multiplex Real-Time PCR assay for SARS-CoV-2 (coronavirus) pathogen detection
- Eurofins Scientific
Eurofins on Wikipedia, Google News & Yahoo Finance
Eurofins on LinkedIn, Twitter & YouTube
Eurofins has 18 subsidiaries including Biomnis, Biomnis Ireland and Boston Heart Diagnostics. Eurofins has 1,544 competitors including Biogen (United States (USA)), Agilyx (United States (USA)) and Neptune Wellness Solutions (Canada).
Contact by email its executives including Gilles Martin 
